These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38811083)

  • 81. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
    Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
    Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The pathogenesis and biochemistry of amyloidosis.
    Cohen AS; Connors LH
    J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antibody-mediated resolution of light chain-associated amyloid deposits.
    Hrncic R; Wall J; Wolfenbarger DA; Murphy CL; Schell M; Weiss DT; Solomon A
    Am J Pathol; 2000 Oct; 157(4):1239-46. PubMed ID: 11021828
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Localized amyloidosis in squamous cell carcinoma of uterine cervix: electron microscopic features of nodular and star-like amyloid deposits.
    Gondo T; Ishihara T; Kawano H; Uchino F; Takahashi M; Iwata T; Matsumoto N; Yokota T
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):225-31. PubMed ID: 8493779
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mechanism of rutin mediated inhibition of insulin amyloid formation and protection of Neuro-2a cells from fibril-induced apoptosis.
    Mahendra VP; Yogendra Prasad K; Ganesan P; Kumar R
    Mol Biol Rep; 2020 Apr; 47(4):2811-2820. PubMed ID: 32240467
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Differential diagnosis of amyloidosis].
    Röcken C
    Verh Dtsch Ges Pathol; 2002; 86():107-15. PubMed ID: 12647358
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
    Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J
    Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.
    Kelly JW
    Curr Opin Struct Biol; 1998 Feb; 8(1):101-6. PubMed ID: 9519302
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats.
    Moccia V; Vogt AC; Ricagno S; Callegari C; Vogel M; Zini E; Ferro S
    PLoS One; 2023; 18(11):e0293892. PubMed ID: 37917747
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.
    Martin EB; Williams A; Heidel E; Macy S; Kennel SJ; Wall JS
    Biochem Biophys Res Commun; 2013 Jun; 436(1):85-9. PubMed ID: 23707811
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ultrastructural analysis of amyloidoma.
    Garcia CA; Abell-Aleff PC; Gamb SI; Miller DV
    Ultrastruct Pathol; 2009; 33(3):123-7. PubMed ID: 19479652
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis.
    García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G
    Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Animal models for reactive amyloidosis.
    Gruys E; Snel FW
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A putative role for cathepsin K in degradation of AA and AL amyloidosis.
    Röcken C; Stix B; Brömme D; Ansorge S; Roessner A; Bühling F
    Am J Pathol; 2001 Mar; 158(3):1029-38. PubMed ID: 11238051
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tracheobronchial AL amyloidosis: histologic, immunohistochemical, ultrastructural, and immunoelectron microscopic observations.
    Toyoda M; Ebihara Y; Kato H; Kita S
    Hum Pathol; 1993 Sep; 24(9):970-6. PubMed ID: 8253463
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Structure of cytotoxic amyloid oligomers generated during disaggregation.
    Kaku T; Ikebukuro K; Tsukakoshi K
    J Biochem; 2024 May; 175(6):575-585. PubMed ID: 38430131
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Half a century of amyloids: past, present and future.
    Ke PC; Zhou R; Serpell LC; Riek R; Knowles TPJ; Lashuel HA; Gazit E; Hamley IW; Davis TP; Fändrich M; Otzen DE; Chapman MR; Dobson CM; Eisenberg DS; Mezzenga R
    Chem Soc Rev; 2020 Aug; 49(15):5473-5509. PubMed ID: 32632432
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Amyloid fibril cytotoxicity and associated disorders.
    Saremi S; Khajeh K
    Prog Mol Biol Transl Sci; 2024; 206():265-290. PubMed ID: 38811083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.